comparemela.com
  1. Home
  2. Live Updates
  3. Prior Warrant - Breaking News

Prior Warrant News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CANNTAB ANNOUNCES CLOSING OF CONVERTIBLE DEBENTURE PRIVATE PLACEMENT, WARRANT EXPIRY EXTENSION AND CORPORATE UPDATE

/PRNewswire/ Canntab Therapeutics Limited ("Canntab" or the "Company") (CSE:PILL) (OTCQB:CTABF) (FRA:TBF1), the leading innovator in cannabinoid and terpene.

Richard goldsteinBarry polisukFirst republic capital corporationCannabis research licenceFrankfurt stock exchangePrnewswire canntab therapeutics limitedCompany onCompany debenturesNeither the canadian securities exchangeHealth canadaCanadian securities exchangeTherapeutics limitedConversion priceClosing dateConvertible debentureMultilateral instrument

CANNTAB ANNOUNCES CLOSING OF CONVERTIBLE DEBENTURE PRIVATE PLACEMENT, WARRANT EXPIRY EXTENSION AND CORPORATE UPDATE

TORONTO, Feb. 1, 2022 /PRNewswire/ Canntab Therapeutics Limited , the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to. | February 2, 2022

United statesRichard goldsteinBarry polisukFirst republic capital corporationCanntab therapeuticsCannabis research licenceFrankfurt stock exchangeCanntab therapeutics limitedUs newswire servicesCompany debenturesNeither the canadian securities exchangeHealth canadaCanadian securities exchangeTherapeutics limitedConversion priceClosing date

CANNTAB ANNOUNCES CLOSING OF CONVERTIBLE DEBENTURE PRIVATE PLACEMENT, WARRANT EXPIRY EXTENSION AND CORPORATE UPDATE

/PRNewswire/ Canntab Therapeutics Limited ("Canntab" or the "Company") (CSE:PILL) (OTCQB:CTABF) (FRA:TBF1), the leading innovator in cannabinoid and terpene.

Richard goldsteinBarry polisukFirst republic capital corporationCannabis research licenceFrankfurt stock exchangePrnewswire canntab therapeutics limitedCompany onCompany debenturesNeither the canadian securities exchangeHealth canadaCanadian securities exchangeTherapeutics limitedConversion priceClosing dateConvertible debentureMultilateral instrument

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.